KATHARINE LORD: Open Payments
NPI 1538304803 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 33 payments from 20 companies in 2025. Trend: 2023 $641 · 2024 $1,166 · 2025 $907
Food & beverage: $837Education: $70
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $133 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Janssen Biotech, Inc. | 3 | $73 |
| ABBVIE INC. | 2 | $55 |
| Genmab U.S., Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Gilead Sciences, Inc. | 1 | $29 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: Epkinly, ENHERTU, KEYTRUDA, IMFINZI, RYBREVANT, TECVAYLI, IMBRUVICA, Trodelvy.
Industry payments across TX — which companies pay providers there.
